The use of SCID mice in biotechnology and as a model for human disease

Critical Reviews in Biotechnology

Volumn 16, Issue 1, 1996, Pages 95-118

  Sandhu, J S ^a,b   Boynton, E ^a   Gorczynski, R ^a   Hozumi, N ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Hematopoietic cells; Human bone; Human peripheral blood lymphocytes; Human skin; Severe combined immunodeficient mice; Xenotransplantation

Indexed keywords

MONOCLONAL ANTIBODY; RECOMBINANT VACCINE;

ANIMAL; BIOSYNTHESIS; BIOTECHNOLOGY; COMBINED IMMUNODEFICIENCY; DISEASE MODEL; GENE THERAPY; GRAFT VERSUS HOST REACTION; HISTOCOMPATIBILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; ISOLATION AND PURIFICATION; LYMPHOCYTE TRANSFUSION; MOUSE; MOUSE MUTANT; REVIEW; XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; BIOTECHNOLOGY; DISEASE MODELS, ANIMAL; GENE THERAPY; GRAFT VS HOST DISEASE; HIV INFECTIONS; HUMANS; LYMPHOCYTE TRANSFUSION; MICE; MICE, SCID; SEVERE COMBINED IMMUNODEFICIENCY; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HETEROLOGOUS; VACCINES, SYNTHETIC;

EID: 0030339071     PISSN: 07388551     EISSN: None     Source Type: Journal    
DOI: 10.3109/07388559609146601     Document Type: Article

References (86)

1. Abedi, M. R., Christensson, B., Islam, K. B., Hammarstrom, L., and Smith, C. E. I. 1992. Immunoglobulin production in severe combined immunodeficient (SCID) mice reconstituted with human peripheral blood mononuclear cells. Eur. J. Immunol., 22: 823-828.
2. Aldrovandi, G. M., Feuer, G., Gao, L., Jamieson, B., Kristeva, M., Chen, I. S. Y., and Zack, J. A. 1993. The SCID-hu mouse as a model for HIV-1 infection. Nature, 363: 732-736.
3. Alegre, M. L., Peterson, L. J., Jeyrajah, D. R., Weiner, M., Bluestone, J. A., and Thistlethwaite, J. R. 1994. Severe combined immunodeficient mice engrafted with human splenocytes have functional human T cells and reject human allografts. J. Immunol., 153: 2738-2748.
4. Avrameas, S. 1991. Natural autoantibodies: from "horror autotoxicas" to "gnothi seauton". Immunol. Today, 12: 154-159.
5. Baum, C. M., Weissman, J. L., Tsukamto, A. S., Buckle, A. M., and Peault, B. 1992. Isolation of a candidate human haematopoietic stem cell population. Proc. Natl. Acad. Sci. U.S.A., 89: 2804-2808.
6. Berek, C., Berger, A., and Apel, M. 1991. Maturation of the immune response in germinal centers. Cell, 67: 1121-1129.
7. Bonyhadi, M. L., Rabin, L., Salimi, S., Brown, D. A., Kosek, J., McCune, J. M., and Kaneshima, H. 1993. HIV induces thymus depletion in vivo. Nature, 363: 728-732.
8. Bosma, G. C., Custer, R. P., and Bosma, M. J. 1983. A severe combined immunodeficiency mutation in the mouse. Nature, 301: 527-530.
9. Bosma, G. C., Davisson, M. T., Ruetsch, N. R., Sweet, H. O., Schultz, L. D., and Bosma, M. J. 1989. The mouse mutation severe combined immunodeficiency (scid) is on chromosome 16. Immunogenetics, 29: 54-57.
10. Bosma, G. C., Fried, M., Caster, R. P., Carroll, A. M., Gibson, D. M., and Bosma, M. J. 1989. Evidence of functional lymphocytes in some (leaky) seid mice. J. Exp. Med., 167: 1016-1033.
11. Boulianne, G. L., Hozumi, N., and Shulman, M. J. 1984. Production of functional chimeric mouse/human antibody. Nature, 312: 6851-6855.
12. Boynton, E., Aubin, J., Gross, A., Hozumi, N., and Sandhu, J. Maintenance of structure and function of viable human bone in the SCID mouse. Submitted.
13. Brennan, F. M. and Feldmann, M. 1992. Cytokines in autoimmunity. Curr. Biol., 4: 754-759.
14. Carlsson, R., Martensson, C., Kalliomark, S., Ohlin, M., and Barrebaeck, C. A. K. 1992. Human peripheral blood lymphocytes transplanted into SCID mice constitute an in vivo culture system exhibiting several parameters found in a normal humoral immune response and are a source of immunocytes for the production of human monoclonal antibodies. J. Immunol., 148: 1065-1071.
15. Carroll, A. M. and Bosma, M. J., 1989. Detection and characterization of functional T cell in mice with severe combined immune deficiency. Eur. J. Immunol., 18: 1965-1971.
16. +) lymphocytes in seid mice. J. Immunol., 143: 1087-1093.
17. Chambers, C. A., Kang, J., and Hozumi, N. 1992. Ectopic lymphokine gene expression in human peripheral blood lymphocytes in vivo. Proc. Natl. Acad. Sci. U.S.A., 89: 1026-1030.
18. Chen, I. S. Y. and Zack, J. A. 1994. Modeling human retroviral pathogenesis and anti-retroviral gene therapy in the SCID mouse. Res. Immunol., 145: 385-392.
19. Davies, T. F., Kimura, H., Fong, P., Kendler, D., Shultz, L. D., Thung, S., and Martin, A. 1991. The SCID-hu mouse and thyroid autoimmunity: characterization of human thyroid autoantibody secretion. Clin. Immunol. Immunopathol., 60: 319-330.
20. Dick, J. E. 1994. Future prospects for animal models created by transplanting human haematopoietic cells into immune-deficient mice. Res. Immunol., 145: 380-384.
21. Dorschkind, K., Pollack, S. B., Bosma, M. J., and Phillips, R. A. 1985. Natural killer (NK) cells are present in mice with severe combined immunodeficiency (SCID). J. Immunol., 134: 3798-3801.
22. Duchosal, M. A., Eming, S. A., Fisher, P., Letereq, D., Barbas, C. F. I., McConahey, P. J., Caothiens, R. H., Thornton, G. B., Dixon, F. J. R., and Burton, D. R. 1992. Immunization of Hu-PBL-SCID mice and the rescue of human monoclonal Fab fragments through combinatorial libraries. Nature, 355: 258-262.
23. Duchosal, M. A., Eming, S. A., McConahey, P. J. R., and Dixon, F. J. The hu-PBL-SCID mouse model. Long-term human serologic evolution associated with the xenogeneic transfer of human peripheral blood lymphocytes into SCID mice. Cell Immunol., 139: 468-477.
24. Elliott, M. J., Maini, R. N., Feldmann, M., Kalden, J. R., Antoni, C., Smolen, J. S., Leeb, B., Breedveld, F. C., Macfarlane, J. D., Bijl, H., and Woody, J., 1994. Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet, 344: 1105-1110.
25. Fulop, G. M. and Phillips, R. A. 1986. Full reconstitution of the immune deficiency in SCID mice with normal stem cells requires low-dose irradiation of the recipients. J. Immunol., 136: 4438-4443.
26. Fulop, G. M. and Phillips, R. A. 1990. The SCID mutation in mice causes a general defect in DNA repair. Nature, 347: 479-482.
27. Geppert, T. D. and Jasin, H. E. 1990. Immunoglobulin (Ig) and autoantibody production in mice with severe combined immunodeficiency (SCID) injected with lymphocytes from patients with systemic lupus erythematosus (SLE). Arthritis Rheum., 33: S99 (abstr.).
28. Griffiths, A. D., Malonqvist, M., Marks, J. D., Bye, J. M., Ebleton, M. J., McCafferty, J., Baier, M., Holliger, K. P., Gorick, B. D., Hughes-Jones, N. C., Hoegenboom, H. R., and Winter, G. 1993. Human anti-self antibodies with high specificity from phage display libraries. EMBO J., 12: 725-734.
29. Habu, S., Fukui, H., Shimamura, K., Kasai, M., Nagai, Y. R., Okumura, K., and Tamaoki, N. 1981. In vivo effects of anti-asialo GM1 reduction of NK activity and enhancement of translated tumor growth in nude mice. J. Immunol., 127: 34-88.
30. Hervé, P., Flesch, M., Tiberghien, P., Wijdenes, J., Racadot, E., Bordigoni, P., Plouvier, E., Stephan, J. L., Bourdeau, H., Holler, E., Lioure, B., Roche, C., Vilmer, E., Demeocq, F., Kuentz, M., and Cahn, J. Y. 1992. Phase I-II trial of a monoclonal anti-tumor necrosis factor α antibody for the treatment of refractory severe acute graft-versus-host disease. Blood, 79: 3362-3368.
31. Hozumi, N. and Sandhu, J. 1993. Recombinant antibody technology: its advent and advances. Cancer Invest., 11: 714-723.
32. Hozumi, N., Gorczynski, R., Peters, W., and Sandhu, J. S. 1994. A SCID mouse model for human immune response and disease. Res. Immunol., 145: 370-379.
33. Huppes, W., Fickenscher, H., Hat, B. A., and Fleckenstein, B. 1994. Cytokine dependence of human to mouse graft versus host disease. Scand. J. Immunol., 40: 26-32.
34. Hurez, V., Kaveri, S.-V., and Kazatchkine, M. D. 1993. Expression and control of the natural autoreactive IgG repertoire in normal human serum. Eur. J. Immunol., 23: 783-789.
35. Kamel-Reid, S. and Dick, J. E. 1988. Engraftment of immuno-deficient mice with human haematopoietic stem cells. Science, 242: 1706-1709.
36. Kamel-Reid, S., Letarte, M., Sirad, C., Doedens, M., Grunberger, T., Fulop, G. M., Freedman, M. H., Philips, R., and Dick, J. E. 1989. A model of human acute lymphoblastic leukemia in immune-deficient SCID mice. Science, 246: 1597-1600.
37. Kaneshima, H., Shih, C.-C., Namikawa, R., Rabin, L., Outzen, H., Machadao, S. G., and McCune, J. M. 1991. Human immunodeficiency virus infection of human lymph nodes in the SCID-hu mouse. Proc. Natl. Acad. Sci. U.S.A., 88: 4523-4527.
38. Karlsson, B. 1991. Treatment of genetic defects in haematopoietic cell function by gene transfer. Blood, 78: 2481-2492.
39. Köhler, G. and Milstein, C. 1975. Continuous culture of fused cells secreting antibody of predefined specificity. Nature, 256: 495-497.
40. Kollmann, T. R., Kim, A., Zhuang, X., Hachamovitch, M., and Goldstein, H. 1994. Reconstitution of SCID mice with human lymphoid and myeloid cell after transplantation with human fetal bone marrow without the requirement for exogenous human cytokines. Proc. Natl. Acad. Sci. U.S.A., 91: 8032-8036.
41. Krams, S. M., Dorshkind, K., and Gerswin, E. 1989. Generation of biliary lesions after transfer of human lymphocytes into severe combined immunodeficient (SCID) mice. J. Exp. Med., 170: 1919-1930.
42. Kirchgessner, C. U., Patil, C. K., Evans, C. A., Cuomo, C. A., Fred, L. M., Carter, T., Ottinger, M. A., and Brown, J. M. 1995. DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect. Science, 267: 1178-1182.
43. Kyoizumi, S., Baum, C. M., Kaneshima, H., McCune, J., Yee, E. J., and Namikawa, R. 1992. Implantation and maintenance of functional human bone marrow in SCID-hu mice. Blood, 79: 1704-1711.
44. Lapidot, T., Pflumo, F., Doedens, M., Murdoch, B., Niliano, D., and Dick, J. 1992. Cytokine stimulation of multilineage human hematopoiesis from immature cells transplanted into SCID mice. Science, 255: 1137-1141.
45. Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Peterson, B., Caligari, M. A., and Dick, J. E. 1994. A cell imitating human acute myeloid leukemia after transplantation into SCID mice. Nature, 367: 645-648.
46. Lubin, I., Segall, H., Marcus, H., David, M., Kulova, L., Steinitz, M., Erlich, P., Gan, J., and Reisner, Y. 1994. Engraftment of human peripheral blood lymphocytes in normal strain of mice. Blood, 83: 2368-2381.
47. Macht, L. M., Corrall, R. J., Banga, J. P., and Elson, C. J. 1993. Control of human thyroid autoantibody production in SCID mice. Clin. Exp. Immunol., 91: 390-396.
48. Manser, T. 1990. The efficiency of antibody affinity maturation: can the rate of B-cell division be limiting? Immunol. Today, 11: 305-308.
49. McCafferty, J., Griffiths, A. D., Winter, G., and Chriswell, F. J. 1990. Phage antibodies: filamentous phage displaying antibody variable domains. Nature, 348: 552-554.
50. McCulloch, E. A., Minden, M. D., Miyauchi, T., Kelleher, C. A., and Wang, C. 1988. Stem cell renewal and differentiation in acute myeloblastic leukemia. J. Cells Sci. Suppl., 10: 267-281.
51. McCune, J. M., Namikawa, R., Kaneshima, H., Shultz, L. D., Lieberman, M., and Weissman, I. L. 1988. The SCID-hu mouse: mourine model for the analysis of human hematolymphoid differentiation and function. Science, 241: 1632-1639.
52. Miller, R. A., Oseroff, R. R., Stratte, P. T., and Levy, R. 1983. Monoclonal antibody therapeutic trials in seven patients with T-cell lymphoma. Blood, 62: 988-995.
53. Mombaerts, P., Iacomini, J., Johnson, R. S., Herrup, K., Tonegawa, S., and Papaioannou, V. E. 1992. Rag1-deficient mice have no mature B and T lymphocytes. Cell, 68: 869-877.
54. Morrison, S. L., Johnson, M. J., Herzenberg, L. A., and Oi, V. T. 1984. Chimeric human antibody molecules: mouse antigen domains with human constant region domains. Proc. Natl. Acad. Sci. U.S.A., 81: 6851-6855.
55. Mosier, D. E., Gulizia, R. J., Baird, S. M., and Wilson, D. B. 1992. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature, 335: 256-259.
56. Murphy, W. J., Bennett, M., Anver, M. R., Baseler, M., and Longo, D. L. 1992. Human-mouse lymphoid chimeras: host-vs-graft and graft-vs-host reactions. Eur. J. Immunol., 22: 1421-1427.
57. Murray, A. G., Patzelbauer, P., Hughes, C. C., Costa, J., Askenase, P., and Pober, J. A. 1994. Human T-cell-mediated destruction of allogeneic micro vessels in severe combined immunodeficient mouse. Proc. Natl. Acad. Sci. U.S.A., 91: 9146-9150.
58. Namikawa, R., Weilbeacher, K. N., Kaneshima, H., Yee, E. J., and McCune, T. M. 1990. Long term human haematopoiesis in the SCID-hu mouse. J. Exp. Med., 172: 1055-1063.
59. Namikawa, R., Ueda, R., and Kyoizumi, S. 1993. Growth of human myeloid leukemia in the human marrow environment of SCID-hu mice. Blood, 82: 2526-2536.
60. Peterson, J. S., Marshall, M. D., Backkeskov, S., Hejnaes, K. R., Hier-Madsen, M., and Dyrberg, T. 1993. Transfer of type I (insulin-dependent) diabetes mellitus associated autoimmunity to mice with severe combined immunodeficiency (SCID). Diabetologia, 36: 510-515.
61. Pflumio, F., Lapidot, T., Murdoch, B., Patterson, B., and Dick, J. E. 1993. Engraftment of human lymphoid cells into new-born SCID mice leads to graft-versus-host disease. Int. Immunol., 5: 1509-1522.
62. Rendt, K. E., Barry, T. S., Jones, D. M., Richter, C. B., McCachren, S. S., and Haynes, B. F. 1993. Engraftment of human synovium into severe combined immunodeficient mice. J. Immunol., 151: 7324-7336.
63. Riechmann, L., Clark, M., and Waldman, H. 1991. Reshaping human antibodies for therapy. Nature, 332: 293-299.
64. Rielly, R. M., Sandhu, J., Alvarez-Diez, T. M., Gallinger, S., Kirsh, J., and Stern, H. 1995. Problems of delivery of monoclonal antibodies. Clin. Pharmacokinet., 28: 126-142.
65. Sandhu, J. 1992. Protein engineering of antibodies. Crit. Rev. Biotechnol., 12: 437-462.
66. Sandhu, J. 1994. A rapid procedure for the humanization of monoclonal antibodies. Gene, 150: 409-410.
67. Sandhu, J., Clark, B., Boynton, E., Keating, A., and Hozumi, N. Characterization of human haematopoiesis in SCID mice implanted with human adult cancellous bone. Submitted.
68. Sandhu, J., Shpitz, B., Gallinger, S., and Hozumi, N. 1994. Human primary immune response in SCID mice engrafted with human peripheral blood lymphocytes. J. Immunol., 152: 3803-3813.
69. Sandhu, J., Gorczynski, R., Shpitz, B., Gallinger, S., Nguyen, H.-P., and Hozumi, N. 1995. Human model of xenogeneic graft versus host disease in SCID mice engrafted with human peripheral blood lymphocytes. Transplantation, 60: 179-184.
70. Schöenbeck, S., Padberg, F., Marx, A., Holifield, R., and Wekerle, H. 1993. Transplantation of myasthenia gravis thymus to SCID mice. Ann. N.Y. Acad. Sci., 681: 66-73.
71. Schols, D., Vandekerckhove, B., Jones, D., and Roncarolo, M.-G. 1994. IL-2 reverses human T cell unresponsiveness induced by thymic epithelium in SCID-hu mice. J. Immunol., 152: 2198-2206.
72. Shinkai, Y., Rathbun, C. T., Lamp, K. P., Oltz, E. M., Stewart, V., Mendelson, M., Charron, J., Datta, M., Young, F., Stall, A. M., and Alt, F. W. 1992. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V (D) J rearrangement. Cell, 68: 855-867.
73. Shiroki, R., Poindexter, N. J., Woodle, S., Hussain, M. S., Mohankumar, T., and Scharp, T. W. 1994. Human peripheral blood lymphocyte reconstituted severe combined immunodeficient (hu-SCID) mice: a model for human islet allograft rejection. Transplantation, 57: 1555-1562.
74. Shpitz, B., Chambers, C. A., Singhal, A. B., Hozumi, N., Fernandes, B. J., Roifman, C. M., Weiner, L. M., Roder, J. C., and Gallinger, S. 1994. High level functional engraftment of severe combined immunodeficient mice with human peripheral blood lymphocytes following pretreatment with radiation and anti-asialo GM. J. Immunol. Methods, 169: 1-15.
75. Shpitz, B., Fernandes, B. J., Mullen, J. B. M., Roder, J. C., and Gallinger, S. 1994. Improved engraftment of human tumours in SCID mice pretreated with radiation and anti-asialo GM1. Anti Cancer Res., 14(5A): 1927-1934.
76. Shultz, L. D., Schweizer, P. A., Christianson, S. W., Gott, B., Schweitzer, I. B., Tennent, B., McKenna, S., Mobraaten, L., Rajan, T. V., Greiner, D. L., and Leiter, E. H. 1995. Multiple defects in innate and adaptive immunologic function NOD/LASZ-scid mice. J. Immunol., 154: 180-191.
77. Söderlind, E., Simonsson, A. C., and Borrebaeck, A. K. 1992. Phage display technology in antibody engineering: design of phagemid vectors and in vitro maturation systems. Immunol. Rev., 130: 109-124.
78. Tary-Lehmann, M. and Saxon, A. 1992. Human mature T cells that are anergic in vivo prevail in SCID mice reconstituted with human peripheral blood. J. Exp. Med., 175: 503-516.
79. Tighe, H., Silverman, G., Kozin, F., Tucker, R., Gilizia, R., Peebles, C., Lotz, M., Rhodes, G., Mosieer, D. E., and Carson, D. A. 1991. Autoantibody production by severe combined immunodeficient mice reconstituted with synovial cells from rheumatoid arthritis patients. Eur. J. Immunol., 20: 1843-1848.
80. Verhoeyen, M., Milstein, C., and Winter, G. 1988. Reshaping human antibodies: grafting an antilysozyme activity. Science, 239: 1534-1536.
81. Vladutiu, A. O. 1994. Can autoimmune diseases be induced in severe combined immunodeficient (SCID) mice? Res. Immunol., 145: 363-370.
82. Wren, S. M., Wang, S. C., Thai, N. L., Conrad, B., Hoffman, R. A., Fung, J. J., Simmons, R. L., and Ilstad, S. T. 1993. Evidence for early Th2 T cell predominance in xeno reactivity. Transplantation, 56: 905-911.
83. Xiang, Z. and Ertl, H. C. J. 1995. Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Cell, 2: 129-135.
84. Xun, C. Q., Thompson, J. S., Jennings, C. D., Brown, S. A., and Widmer, M. B. 1994. Effect of total body irradiation, bisulfan-cyclophosphamide or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2 incompatible transplanted SCID mice. Blood 83: 2360-2367.
85. Yoshikawa, N., Arreaza, G., Morita, T., Mukuta, T., Resetkova, E., Akasu, F., Miller, N., Jamiesen, C., and Volpé, R. 1994. Effect of removing human Graves' thyroid xenografts after eight weeks in nude mice and rexenografting them into SCID mice. J. Clin. Endocrinol. Metab., 78: 367-374.
86. Sandhu, J. et al., unpublished observations.